Sidley Advises PhaseV in Its US$50 Million Series A Financing

Sidley advised PhaseV Trials Inc., a leader in AI/ML-driven clinical development, in its US$50 million Series A financing round. The round was co-led by Accel and Insight Partners, with participation from Viola Ventures, Exor Ventures, and LionBird.

For additional information, please refer to the press release.

The Sidley team was led by Dr. Idan Netser and Jake Funk (Emerging Companies and Venture Capital).